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optimize vaccination in adult population. Activities focus on
four basic areas:
Community-oriented education: travel-oriented
brochures and handouts, travel medicine newsletters
and travel warning.
Health care professional education: Seminars and sym-
posia, medical rounds, periodic work meetings and annual
courses.
Research: Characterization of medical consults.
Medical assistance: pre-travel consult, speciﬁc medi-
cal record, tailored counseling, telephone and electronic
real-time support and referral to local reference medical
centers. Post travel medical evaluation of asymptomatic
long-term travellers, prompt diagnosis and treatment of
symptomatic travellers and epidemiological surveillance
activities.
Results: Between 1992 and 2008 the TMWG has counseled
54,100 travelers. The average annual consult increase was
25% in last four years. In 1998 only 11.8% of high-risk travel-
ers consulted with enough anticipation; in 2008, 24%. 0.4% of
a sample of travelers came to our center referred by travel
agencies and 0.5% by embassies. Routine and special vac-
cine shots increased progressively each year. In a group of
10-50 years old travelers, 8.3% were susceptible to chicken-
pox, 11.4% to mumps, 10.2% to rubella and 8.9% to measles.
Hepatitis A seroprevalence was 40%.
Conclusion: Our experience shows this new medical spe-
cialty is increasingly demanded. We must deepen our work
in an interdisciplinary manner to obtain traveler referrals
from embassies and travel agencies, because of individual
and community travel associated health risks.
The development of TMWG has created awareness of
the need for pre travel advice in the medical and general
community and provides opportunities to update routine
vaccinations in adults.
doi:10.1016/j.ijid.2010.02.1799
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Proﬁle of imported malaria in travelers from the north of
Portugal
A. Silva1,∗, A.R. Silva1, T. Teixeira1, H. Coelho1, R. Sar-
mento e Castro2
1 Hospital Joaquim Urbano, Porto, Portugal
2 Porto, Portugal
Background: Malaria was irradicated from Portugal since
the 50s, but every year, hundreds of Portuguese travelers
arriving from Malaria Endemic Countries are diagnosed plas-
modium positive.
The objective of this study is to investigate the clini-
cal and epidemiological imported malaria between January
2004 and October 2009 in the Travel Medicine Departament
of Hospital Joaquim Urbano in Porto - Portugal.
Methods: Review of the records and datas of 160 malaria
diagnosed positive cases, conﬁrmed by microscopy, in
the last 6 years.Variables analyzed: age, gender, country
visited, pre-travel consultation, chemoprophylaxis, plas-
modium species, reason of travel and symptoms.
Results: The average age of the 160 patients was 42,18
years old. From this group 108 patients (67,5%) were male.
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The main visited countries were Angola with 92 cases
57,5%), followed by Mozambique with 23 (14,4%), São Tomé
ith 7 (4,8%), and the rest distributed over ﬁfteen other
ountries.The most common agent of plasmodium identi-
ed by laboratorial exam was P.falciparum with 31 cases
19,38%), followed by P.vivax with 26 (16,25%). Although, in
1 cases (56,88%) was not possible to detect the plasmodium
pecies.
The malaria chemoprophylaxis was not made by 85
atients (53,12%). Those who did it, 38 (84,44%) took meﬂo-
uine.
The inpatient ratio was 43 (26,88%) of the 160, with a
atal case (0,63%).
Conclusion: The geographic areas of acquisition were
he former Portuguese Colonies in Africa, with 78,75% of
mported malaria.
The P. falciparum was the most frequent species.
Another problem was the diagnosis made by microscopy
ith lower parasitemia, that did not identify the plasmod-
um species. By this reason, more sensitive and accurate
ethods must be used.
To reduce risk of imported malaria, all travelers should
ave a pre-travel counselling, somajor investment is advised
o be made in this important emerging ﬁeld of Travel
edicine in Portugal.
oi:10.1016/j.ijid.2010.02.1800
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Boston Medical Center, Boston, MA, USA
Boston University, Boston, MA, USA
Boston University School of Public Health, Boston, MA, USA
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Background: Travelers to Central America (CAm), South
merica (SAm) and the Caribbean may face regional
ravel-related health risks. Our objective is to describe
emographics, trip characteristics and differences in pre-
ravel antimalarial prescriptions for travelers to CAm, SAm
nd the Caribbean.
Methods: Demographics, health, and trip information was
ollected for travelers seen in the 5 clinics of the Boston
rea Travel Medicine Network (BATMN) from March 1, 2008
o September 30, 2009. For analysis, Mexico was included in
he CAm category.
Results: Of 9203 travelers seen in participating clinics,
834 (30.8%) planned to visit CAm, SAm and the Caribbean
ncluding 1411 (49.8%) to SAm. Travelers to CAm and SAm
ere predominantly white (>80%) and less often black (2.6%)
ompared with 58.3% white and 20.8% black travelers to the
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aribbean. Most trips (71.6%, 53.8%, and 72.8% for CAm,
Am and the Caribbean respectively) were <2 weeks dura-
ion. Most traveled for tourism (53.7%, 56.6% and 30.3%
f visitors to CAm, SAm and the Caribbean) while visiting
riends/relatives (VFR) accounted for 7.3%, 13.5% and 23.7%
f visits to these regions, respectively. Caribbean and CAm
ravelers also went for missionary/volunteer work (21.9%
nd 13.3%). Travelers to the Caribbean were more likely
o stay at a local residence (49.8%) than those traveling to
Am or SAm (27.9%/31.9%); however, CAm and SAm travel-
rs were more likely to stay at a hotel/hostel (70%) than
aribbean travelers (40%). More travelers to CAm (65.6%)
nd the Caribbean (68.8%) visited a malaria risk country than
hose traveling to SAm (43.6%). Of the Caribbean travelers
ho were prescribed antimalarials, the vast majority (96%)
ere visiting Haiti and the Dominican Republic. Caribbean
nd CAm travelers were predominantly prescribed chloro-
uine (82.3% and 74.5%) or Malarone (18.6% and 23.7%);
Am travelers appropriately received Malarone (85.4%) or
oxycycline (8.2%).
Conclusion: Caribbean travelers were more likely to
ravel as VFRs or volunteers and stay in local residences than
hose traveling to CAm or SAm. South American travelers vis-
ted for longer periods of time and often to non-malarious
reas. All travelers received antimalarials appropriate for
heir destinations.
oi:10.1016/j.ijid.2010.02.1801
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ookworm-related cutaneous Larva Migrans: An annoying
ouvenir of some trips
. Lloveras1,∗, S.E. Echazarreta2, T. Orduna1
Corunna, Argentina
Hospital F.J.Mun˜iz, Buenos Aires, Argentina
Background: Hookworm-related Cutaneous Larva Migrans
HrCLM) in travellers is a common but neglected parasitic
kin disease that results from a zoonotic nematode infec-
ion and shows a characteristic creeping eruption due to
enetration and migration of the larva within the epidermis.
Methods: We performed a retrospective survey of
atients with this illness assisted at our Unit from 1999
rough 2008.
Results: A total of 64 individuals received a diagnosis of
rCLM, and among them there were 55 (85.93%) who had
cquired it in the Brazilian beaches, but also in Costa Rica,
araguay, Peru, Senegal, Thailand and Venezuela.
Three patients were domestic travelers and they had
cquired the creeping eruption in Argentina. Fifty percent of
he 64 affected patients were young adults between 20—39
ears. Lesions were mainly unique (90.6%) and affected feet
82.75%).
The symptoms appeared to 70.35% (n = 45) of patients,
etween 3 and 7 days after returning from the trip. Eleven
17.18%) patients had secondary bacterial infection. Out
f 64 patients assisted, 62 (96.87%) were cured by a
ingle course of treatment: 48 patients with ivermectin,
1 with oral thiabendazole plus topics of 10% thiaben-
azole cream; one received oral albendazole, 400mg a
ay for 3 days and one patient’s treatment was not
1
c
e
Hternational Congress on Infectious Diseases (ICID) Abstracts
ecorded. Two patients (3.12%) required a second course of
herapy.
Conclusion: As travel to the tropics increases, many trav-
lers may be returning to their countries with this infection,
hich is often misdiagnosed or incorrectly treated.
Although there are various treatments available, it is nec-
ssary to have prospective and randomized controlled trial
o compare their efﬁcacy.
Among the preventive measures, that can be suggested
o travelers, are to avoid walking barefoot has proved to
ecrease the disease impact and also reduce the contact of
kin areas with contaminated soil or beaches, by lying on a
anvas for sunbathing or to rest. Furthermore, Public Health
easures must be put into practice to avoid the presence of
oose animals and to promote deworming of the same.
oi:10.1016/j.ijid.2010.02.1802
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mmunocompromised travellers in the pre-travel appoint-
ent: A report from Portugal
. Coelho1,∗, C. abreu2, F. Danina1, J. Nuak1, C. Caldas1,
. Quintas1, N. Darwich1, A. Sarmento3
Hospital Sao Joao, Porto, Portugal
hospital s. joão, Porto, Portugal
Hospital S. João, Porto, Portugal
Background: As both international travel and the num-
er of immunocompromised travellers increase, concerns
elated to the efﬁcacy of immunizations and malaria pro-
hylaxis, drug interactions and worse of the basal medical
ondition in this population are a challenge for practitioners.
Methods: The charts from pre-traveller appointments
f consecutive travellers were reviewed selecting our
arget population: those with HIV infection, malignant
iseases in treatment, solid organ or stem cell recep-
ors, under immunossupressive therapy and splenectomized.
emograﬁc data, destination, duration and reasons of
ravel, malaria quimioprophylaxis and immunizations were
onsidered.
Results: From the 2101 travelers 23 (1,1%) meet crite-
ia for immunosuppression. Eleven (48%) had HIV infection
all with CD4+ counts between 200-500/ul, 5 AIDS, 8 under
AART, 3 HCV co-infected), 10 (43%) were under immunosup-
ressive drugs (7 had autoimmune diseases, 2 solid organ
ransplant receptors, 1 under systemic corticotherapy for
evere asthma), 2 (9%) were splenectomized. Their ages
anged from 21-56 years, mean 41; 17 (74%) were man. Mean
ime between the consultation and the date of travel was
3 days. Africa was the destination of 16 (70%) travelers
13 for Angola), tropical South America in 5 (22%), Indian
ubcontinent and Central America in 1 each. Excluding 2
ravelers (one emigrant and one who lived in the country
f destination) the duration of travel ranged from 3-180
ays, mean 29days. The reason for travelling was work in
2 (52%), tourism in 9 (39%), humanitarian mission in 1 and
was resident. Malaria quimioprophylaxis was indicated in
2 (52%) and in 3 drug interactions changed the the ﬁrst
hoice. Yellow fever vacination was required for 12 travel-
rs, in 6 a medical excuse was done, 4 were vaccinated (2
IV not severe immunosuppressed, 1 was splenectomized,
